Jennison Associates’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-466,724
| Closed | -$4.84M | – | 663 |
|
|
2017
Q4 | $4.84M | Sell |
466,724
-425,927
| -48% | -$4.41M | ﹤0.01% | 494 |
|
|
2017
Q3 | $14.2M | Sell |
892,651
-126,362
| -12% | -$2.01M | 0.01% | 446 |
|
|
2017
Q2 | $12.3M | Buy |
1,019,013
+475,164
| +87% | +$5.75M | 0.01% | 455 |
|
|
2017
Q1 | $11.3M | Sell |
543,849
-26,352
| -5% | -$547K | 0.01% | 478 |
|
|
2016
Q4 | $8.15M | Buy |
570,201
+874
| +0.2% | +$12.5K | 0.01% | 489 |
|
|
2016
Q3 | $9.37M | Sell |
569,327
-1,154
| -0.2% | -$19K | 0.01% | 475 |
|
|
2016
Q2 | $8.07M | Buy |
570,481
+106,349
| +23% | +$1.5M | 0.01% | 468 |
|
|
2016
Q1 | $6.58M | Buy |
+464,132
| New | +$6.58M | 0.01% | 473 |
|